Yetmişdokuz akciğer kanserli olgunun cerrahi tedavi analizleri

Amaç: Bu çalışmanın amacı; Primer bronş kanserli hastalarda uygun adjuvant tedavilerle operasyon zamanlaması, operasyon endikasyonları, cerrahi tekniğin seçimi, postoperatif komplikasyonlar ve postoperatif cerrahinin küratifsonuçlarının günümüz literatür bilgileri ile değerlendirilmesidir. Yöntemler: Gazi Üniversitesi Tıp Fakültesi, Göğüs Cerrahisi Anabilim Dalı’nda Haziran 2002-Mart 2005 tarihleri arasında Primer Bronş Kanseri tanısı ile takip edilen ve cerrahi tedavi uygulanan 79 hasta (69 erkek, 10 kadın) retrospektif olarak değerlendirildi. Bulgular: Kliniğimizde Haziran 2002-Mart 2005 tarihleri arasında, 79 Primer bronş kanserli olguya cerrahi tedavi uygulandı. Olguların %87.3’ü erkek (n=69), %12.7’si kadın (n=10) olup yaş aralığı 38-82 (ort: 60.25±10.32) arasındaidi. Olguların 77’sinde küçük hücreli dışı akciğer kanseri (KHDAK), 2’sinde küçük hücreli akciğer kanseri (KHAK) tanısı elde edildi. KHDAK’li (%97.45 n=77) hastaların patolojik evrelere göre dağılımı; %2.55 (n=2) karsinoma insitu, %39.2 (n=31) evre I, %19 (n=15) evre II, %32.9 (n=26) evre III, %3.8 (n=3) evre IV olarak saptandı.Sonuç: Cerrahi tedavi KHDAK’de en önemli tedavi yöntemidir. Bununla birlikte cerrahinin kendisi de morbidite ve mortalite kaynağı olabilmektedir. Bu sorunları en aza indirmek için hasta seçimi iyi yapılmalı, preoperatif hazırlıkdönemi iyi değerlendirilip hastanın cerrahi için performansı mümkün olan en üst düzeye çıkarılmalıdır. (Gazi Med J 2011; 22: 79-84)

Analysis of surgical treatment of 79 lung cancer cases

Objective: The aim of this study is evaluation of operation timing in patients who suffered primary bronchial cancers with proper adjuvant therapies, indications for operation, selection of surgical method, postoperative complications and curative results of surgical attempts in the light of current literature. Methods: Seventy-nine patients (69 males-10 females) who were diagnosed and operated on with primary bronchial cancer, and followed between June 2002 and March 2005 at the Department of Thoracic surgery, Faculty ofMedicine, Gazi University, were evaluated retrospectively. Results: Seventynine patients with primary bronchial cancer were operated on between June 2002 and March 2005 in our department. 87.3% of these cases were male (n=69), and 12.7% were female (n=10), median age of patients was 60.25±10.32 (38-82). 77 cases were diagnosed as non small lung cancer (NSLC) and 2 cases were diagnosed as small lung cancer (SLC). The patients were classified according to pathological stage as follows; 2.55% ofthe patients as carcinoma in situ (n=2), 39.2% of the patients as stage I (n=31), 19% of the patients as stage II (n=15), 32.9% of the patients as stage III (n=26), 3.8% of the patients as stage IV (n=3).

PDF

___

1. Hayata Y, Kato H, Konaka C, Amemiya R, Ono J, Ogawa I, et al. Photoradiation therapy with hematoporphyrin derivative in early and stage I lung cancer. Chest 1984; 86: 169-77.
2. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997; 72: 595-602.
3. Takizawa T, Haga M, Yagi N, Terashima M, Uehara H, Yokoyama A, Kurita Y. Pulmonary function after segmentectomy for small peripheral carcinoma of the lung. J Thorac Cardiovasc Surg 1999; 118: 536-41.
4. Ginsberg RJ, Martini N. Non-small cell lung cancer: surgical management. In Pearson FG. Thoracic Surgery. Churchill, Livingstone, New York 2002; 837-59.
5. Icard P, Regnard JF, Guibert L, Magdeleinat P, Jauffret B, Levasseur P. Survival and prognostic factors in patients undergoing parenchymal saving bronchoplastic operation for primary lung cancer: A series of 110 con-secutive patients. Eur J Cardiothorac Surg 1999; 15: 426-32.
6. AJCC Cancer Staging Manual, Chapter 19, 5th ed. Philadelphia, Lippin-cott-Raven, 1997.
7. American Cancer Society: Cancer Facts and Figures 2001, Atlanta, American Cancer Society.
8. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111: 1710-7.
9. Mountain CF. The International System for Staging Lung Cancer. Seminars Surg Oncol 2000; 18: 106-15.
10. Nesbitt JC. Superior vena cava syndrome: surgery and stents. Pass HI, Mitchell JB, Jhonson DH, Turrisi AF, Minna JD. Lung cancer principle and practice Lippincott Williams &Wilkins, Philadelphia 2000, S. 1056-70.
11. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000; 343: 1217-22.
12. Dartevelle P, Macchiarini P. Surgical management of superior sulcus tu-mors. Oncologist 1999; 4: 398-407.
13. Ichinose Y, Tsuchiya R, Kato H. Randomized trial of chemotherapy versus surgery for stage IIIA non-srnall cell lung cancer. Lung Cancer 2000; 29: 173.
14. Spaggiari L, Solli P, Leo F. Tracheal sleeve and superior vena cava resection for bronchogenic carcinoma. Lung Cancer 2000; 29: 135.
15. Vaporciyan AA, Rice D, Correa AM, Walsh G, Putnam JB, Swisher S, Smyth R, Roth J. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur J Cardiothorac Surg 2002; 22: 47-52.
16. Kraut M, Wozniak A. Clinical presentation. Lung cancer principle and practice. In Pass HI, Mitchell JB, Jhonson DH, Turrisi AF, Minna JD (eds). Lippincott Williams &Wilkins Philadelphia 2000, S. 521-34.
17. Çıkrıkçıoğlu S. Prognostik faktörler ve tedavi öncesi değerlendirme. Akciğer kanseri; multidisipliner yaklaşım. In Akkoçlu A, Öztürk C (eds). Toraks Kitapları. Ankara: Bilimsel Tıp Yayınevi; 1999; 1: 81-3.
18. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003; 348: 2535-42.
19. Schuurmans MM, Diacon AH, Bolliger CT. Functional evaluation before lung resection. Clin Chest Medicine 2002; 23: 159-72.
20. Deslauriers J, Ginsberg RJ, Dubois P, Beaulieu M, Goldberg M, Piraux M. Current operative morbidity associated with elective surgical resection for lung cancer. Can J Surg 1989; 32: 335-9.